What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Pathology
His primary areas of investigation include Pathology, Carcinoma, Ovary, Adenocarcinoma and Immunohistochemistry.
His Pathology study combines topics in areas such as Transitional cell carcinoma, Urinary bladder and Ovarian tumor.
His work carried out in the field of Carcinoma brings together such families of science as Stage, Tuberous sclerosis and Serous fluid.
His study in Ovary is interdisciplinary in nature, drawing from both Dermoid cyst, Staining, Thyroid and Broad ligament.
His Adenocarcinoma research incorporates elements of Cervix, Squamous Differentiation and Atypia.
His research integrates issues of Testicle, Anatomy, Sertoli Cell Tumor and Hyaline in his study of Immunohistochemistry.
His most cited work include:
- The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma (2002 citations)
- The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder (1309 citations)
- WHO classification of tumours of female reproductive organs (626 citations)
What are the main themes of his work throughout his whole career to date?
Robert H. Young mostly deals with Pathology, Ovary, Carcinoma, Adenocarcinoma and Differential diagnosis.
His Pathology research is multidisciplinary, incorporating perspectives in Ovarian tumor, Metastasis and Anatomy.
His research in Carcinoma focuses on subjects like Urinary bladder, which are connected to Transitional cell carcinoma.
He interconnects Hyperplasia and Cervix in the investigation of issues within Adenocarcinoma.
He combines topics linked to Eosinophilic with his work on Differential diagnosis.
Robert H. Young is interested in Cytokeratin, which is a field of Immunohistochemistry.
He most often published in these fields:
- Pathology (84.38%)
- Ovary (19.37%)
- Carcinoma (15.77%)
What were the highlights of his more recent work (between 2013-2021)?
- Pathology (84.38%)
- Ovary (19.37%)
- Eosinophilic (7.06%)
In recent papers he was focusing on the following fields of study:
Robert H. Young focuses on Pathology, Ovary, Eosinophilic, Differential diagnosis and Stromal cell.
Robert H. Young works mostly in the field of Pathology, limiting it down to concerns involving Biography and, occasionally, Portrait.
He combines subjects such as Follicle, Ovarian tumor and Endocrine pathology with his study of Ovary.
His Eosinophilic research is multidisciplinary, incorporating elements of SDHB, Mitotic index, Biopsy, Renal cell carcinoma and Hyaline.
The various areas that Robert H. Young examines in his Differential diagnosis study include Clear cell carcinoma, Embryonal carcinoma, Neoplasm, Serous fluid and Immature teratoma.
His work deals with themes such as Thecoma, Stroma and Fibroma, which intersect with Stromal cell.
Between 2013 and 2021, his most popular works were:
- WHO classification of tumours of female reproductive organs (626 citations)
- Renal cell carcinoma in tuberous sclerosis complex. (119 citations)
- ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. (59 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Pathology
His primary areas of study are Pathology, Differential diagnosis, Carcinoma, Stromal cell and Ovary.
His Pathology research is multidisciplinary, relying on both Metastasis and Anatomy.
His biological study spans a wide range of topics, including Follicle, Luteoma, Clear cell carcinoma and Small-cell carcinoma.
His Carcinoma research incorporates themes from Mixed Germ Cell Tumor, Embryonal carcinoma, Testicular Embryonal Carcinoma, Urachus and Mucinous cystadenocarcinoma.
His Stromal cell study incorporates themes from Genetic predisposition, Thecoma, Hormone, Fibroma and Atypia.
His Ovary study combines topics from a wide range of disciplines, such as Cystadenocarcinoma and Cystadenoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
